By Rédaction Africa Links 24 with Damian Garde
Published on 2024-01-17 14:23:47
If you want to keep updated on the latest in biotech science and politics, sign up for our biotech newsletter to receive all the latest news directly to your inbox.
Good morning, everyone! Here’s the latest on a biotech startup downsizing, a groundbreaking cancer treatment idea, and some important upcoming events in the industry.
Kyverna Therapeutics, a biotech company working on CAR-T therapies for autoimmune diseases, has filed for an initial public offering. The company’s lead product, KYV-101, is a personalized cell therapy targeting CD19 for lupus nephritis, and is currently being tested in a mid-stage clinical trial.
In other news, Dewpoint Therapeutics, a well-funded biotech startup, has made the difficult decision to lay off 15% of its workforce after facing setbacks with two major partnerships. For the full story, you can read more on STAT+.
With all these exciting developments happening in the biotech industry, it’s crucial to stay informed about the latest news and advancements. By signing up for our biotech newsletter, you can make sure that you never miss out on important updates and breakthroughs.
Don’t miss out on the latest news in the fast-paced world of biotech- sign up for our newsletter today!
Read the original article on Africa Health News
